Kalvista Pharmaceuticals Inc.

09/24/2026 | Press release | Archived content

On-demand Treatment of Hereditary Angioedema Attacks With Sebetralstat in Adolescents: Interim Analysis From KONFIDENT-S

Kalvista Pharmaceuticals Inc. published this content on September 24, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2026 at 19:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]